ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 143 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $13,674,000 | +60.2% | 725,000 | 0.0% | 0.01% | +40.0% |
| Q2 2019 | $8,533,000 | -13.8% | 725,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $9,896,000 | +94.5% | 725,000 | +196.4% | 0.01% | +66.7% |
| Q1 2017 | $5,088,000 | 0.0% | 244,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $5,088,000 | -37.9% | 244,600 | -2.2% | 0.00% | -25.0% |
| Q3 2016 | $8,193,000 | +31.2% | 250,000 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $6,243,000 | -65.9% | 250,000 | -60.3% | 0.00% | -62.5% |
| Q4 2014 | $18,311,000 | +115.5% | 629,472 | -6.1% | 0.01% | +100.0% |
| Q3 2014 | $8,498,000 | -48.4% | 670,200 | -18.3% | 0.00% | -42.9% |
| Q2 2014 | $16,467,000 | – | 820,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |